Phosphagenics CEO steps down


Monday, 22 July, 2013

Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.

The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.

The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.

Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.

Related News

Cancer drug eliminates bone metastasis in lab models

Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...

TGA rejects Alzheimer's drug due to safety concerns

The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd